Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia†

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Piperacillin pharmacokinetics and target attainment in children with cancer and fever: Can we optimize our dosing strategy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Need for Hospitalization due to SARS-CoV-2 in Children: A Population-based Estimate

    Research output: Contribution to journalLetterpeer-review

  3. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. PREVALENCE OF SARS-COV-2-ANTIBODIES IN DANISH CHILDREN AND ADULTS

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. A qualitative study of adolescent cancer survivors perspectives on social support from healthy peers - A RESPECT study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Relapse-enriched somatic variants drive drug resistance in childhood acute lymphoblastic leukemia. We used digital droplet-based polymerase chain reaction to establish whether relapse-enriched mutations in emerging subclones could be detected in peripheral blood samples before frank relapse. Although limitations in sensitivity for some probes hindered detection of certain variants, we successfully detected variants in NT5C2 and PRPS1 at a fractional abundance of 0.005% to 0.3%, 41 to 116 days before relapse. As mutations in both these genes confer resistance to thiopurines, early detection protocols using peripheral blood could be implemented to preemptively alter maintenance therapy to extinguish resistant clones before overt relapse.

Original languageEnglish
JournalPediatric Blood & Cancer
Volume67
Issue number7
Pages (from-to)e28306
ISSN1545-5009
DOIs
Publication statusPublished - Jul 2020

    Research areas

  • Biomarkers, Tumor/blood, Case-Control Studies, Child, Clone Cells/metabolism, Combined Modality Therapy, Feasibility Studies, Female, Follow-Up Studies, Humans, Mutation, Neoplasm Recurrence, Local/blood, Polymerase Chain Reaction, Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood, Prognosis

ID: 62070214